Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

IDIENCE CO., LTD.

Home Clinical Trial Sponsors and OrganizationsIDIENCE CO., LTD.

IDIENCE CO., LTD.

ACTIVE

Ildong Holdings Office Bldg., Seoul, 首尔特别市, South Koreawww.idience.comHolding11–50 employeesEstablished: 2019-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

4

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2019

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

100.0%

Trial Status Distribution

Active, not recruiting

1

25.0%

Completed

3

75.0%

Clinical Trials

Trials sponsored by this organization (4)

Food Effect Study of IDX-1197 in Healthy Subjects

Jan 202237 participants

Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer

Active, not recruiting

Jun 202187 participants

Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

Nov 2019108 participants

Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

Aug 201732 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials4
Approvals
News

Back to Organizations